Firefly Neuroscience partners with Next Health on cognitive health platform

Go back to Firefly Neuroscience partners with Next Health on cognitive health platform

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

July 28, 2026 7:50 AM EDT

FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week   

These two peptides have attracted growing scientific interest for their potential neuroprotective and cognitive-supportive properties

Collaboration represents a significant step toward making precision cognitive care more measurable, scalable, and clinically actionable   

KENMORE, N.Y. and LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (Firefly) (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience, and Next Health, a global leader in health optimization and longevity, today announced a... More